Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date

Overview of attention for article published in Journal of Blood Medicine, August 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

USE OF THE ANTI-P-SELECTIN ANTIBODY CRIZANLIZUMAB FOR TREATING SICKLE CELL NEPHROPATHY…

Application WO-2021024220-A1

World Intellectual Property Organisation (WIPO)